Each month FDA will update a publicly available cumulative posting of all drugs designated as orphan drugs. These postings will contain the following information:

1. (a) The name and address of the sponsor;
2. (b) The generic name and trade name, if any, or, if neither is available, the chemical name or a meaningful descriptive name of the drug;
3. (c) The date of the granting of orphan-drug designation;
4. (d) The designated use in the rare disease or condition; and
5. (e) If the drug loses designation after August 12, 2013, the date of it no longer having designation.

[78 FR 35134, June 12, 2013]